Re-evaluate the Efficacy and Safety of Human Urinary Kallidinogenase (RESK): Protocol for an Open-Label, Single-Arm, Multicenter Phase IV Trial for the Treatment of Acute Ischemic Stroke in Chinese Patients
Crossref DOI link: https://doi.org/10.1007/s12975-017-0527-5
Published Online: 2017-03-06
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ni, Jun
,
Qu, Jiazhi
Yao, Ming
Zhang, Zhijun
Zhong, Xihua
Cui, Liying
License valid from 2017-03-06